• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CenterWell Partners with Thyme Care for Comprehensive Cancer Care Support

    12/15/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email

    Partnership began Dec. 1, and extends to patients in seven states

    Senior-focused primary care providers CenterWell Senior Primary Care® and Conviva Senior Primary Care® are now partnering with Thyme Care to provide comprehensive cancer care support for eligible patients.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215558436/en/

    Through Thyme Care, patients in Florida, Georgia, Nevada, North Carolina, South Carolina, Tennessee and Texas have 24/7 access to a virtual team of oncology-trained clinicians, personalized navigation, and proactive support that helps them manage their diagnosis, stay connected to their care team, and avoid unnecessary hospital visits.

    Cancer care accounts for more than 10 percent of all Medicare spending, and the need for better coordination continues to grow as more patients live longer with complex conditions. Navigating a diagnosis can be overwhelming for patients and requires close collaboration between primary and oncology care to ensure patients receive the right support at every stage. Thyme Care strengthens that connection by partnering with CenterWell and Conviva physicians to extend continuous, integrated care into the cancer journey, offering personalized support that improves coordination, enhances communication, and lowers the total cost of care.

    "Our primary care physicians build deep, trusted relationships with patients, which is the foundation for helping them live healthier, more fulfilling lives," said Dr. Sanjay Shetty, President of CenterWell. "With Thyme Care, we are extending that same level of compassionate, coordinated care to the cancer journey. Our patients benefit from an extra layer of support, and our physicians gain a specialized team focused on improving outcomes and easing the burden of cancer care."

    As more risk-bearing providers and payers transition to value-based care, CenterWell's agreement with Thyme Care represents a scalable model for improving outcomes in complex specialty conditions such as cancer. Eligible CenterWell and Conviva patients have access to Thyme Care's suite of services, including:

    • Continuous, high-touch patient support: Thyme Care's virtual team of oncology-trained nurse practitioners, nurses, social workers, and care partners provides 24/7 access to navigation and support. The team helps patients manage symptoms, coordinate appointments, and connect with high-value oncology practices for faster access to care.
    • Access to community-based resources and social work support: Thyme Care identifies social and financial barriers to care and connects patients with local resources such as transportation, meal programs, and financial assistance. Its oncology social workers provide specialized emotional and practical support, helping patients manage the challenges of treatment and maintain stability throughout their cancer journey.
    • Palliative and urgent care support: Thyme Care provides proactive symptom management to prevent emergency visits and integrates palliative care early in the cancer journey to ensure treatment aligns with each patient's goals and preferences.

    "A cancer diagnosis is one of the most challenging and complex experiences that patients and their families will face in the health care system, often requiring them to navigate multiple providers and treatment decisions," said Dr. Brad Diephuis, President and Chief Operating Officer at Thyme Care. "Thyme Care extends the work of CenterWell's primary care teams by providing continuous support that helps patients manage this complexity. Our collaboration demonstrates how primary and oncology care can work together to improve quality and lower costs. By integrating continuous support, proactive symptom management, and palliative care, we are creating a model that helps patients navigate cancer with greater confidence and clarity."

    Patients in the locations listed can check with their providers and insurance companies to determine eligibility, should they need Thyme's services.

    About CenterWell

    CenterWell is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and most of all, personalized. As the largest provider of senior-focused primary care, one of the leading providers of home health care, and a leading integrated home delivery, specialty, hospice, and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE:HUM). Learn more about what we offer at CenterWell.com.

    About Thyme Care

    Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit https://www.thymecare.com/.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251215558436/en/

    For more information about CenterWell and Conviva, contact:

    Lisa Ferguson

    Lferguson16@humana.com

    For more information about Thyme Care, contact:

    Kimberly Dreisinger

    kimberly@thymecare.com

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    More analyst ratings

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    CenterWell Partners with Thyme Care for Comprehensive Cancer Care Support

    Partnership began Dec. 1, and extends to patients in seven states Senior-focused primary care providers CenterWell Senior Primary Care® and Conviva Senior Primary Care® are now partnering with Thyme Care to provide comprehensive cancer care support for eligible patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215558436/en/ Through Thyme Care, patients in Florida, Georgia, Nevada, North Carolina, South Carolina, Tennessee and Texas have 24/7 access to a virtual team of oncology-trained clinicians, personalized navigation, and proactive support that helps them manage their diagnosis, stay connected to their care team, a

    12/15/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana upgraded by Jefferies with a new price target

    Jefferies upgraded Humana from Hold to Buy and set a new price target of $313.00

    12/5/25 8:31:42 AM ET
    $HUM
    Medical Specialities
    Health Care

    Goldman initiated coverage on Humana with a new price target

    Goldman initiated coverage of Humana with a rating of Sell and set a new price target of $235.00

    10/14/25 8:50:11 AM ET
    $HUM
    Medical Specialities
    Health Care

    Evercore ISI initiated coverage on Humana with a new price target

    Evercore ISI initiated coverage of Humana with a rating of In-line and set a new price target of $295.00

    9/22/25 8:31:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gordon converted options into 765 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    11/4/25 9:45:30 AM ET
    $HUM
    Medical Specialities
    Health Care

    President, Insurance Renaudin George Ii converted options into 609 units of Humana Common and covered exercise/tax liability with 240 units of Humana Common, increasing direct ownership by 2% to 16,071 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    10/3/25 9:13:54 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Feinberg David T

    4 - HUMANA INC (0000049071) (Issuer)

    10/2/25 1:07:38 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    Humana Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    12/16/25 8:05:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - HUMANA INC (0000049071) (Filer)

    12/1/25 7:30:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Humana Inc.

    10-Q - HUMANA INC (0000049071) (Filer)

    11/5/25 12:07:03 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

    Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,00

    11/5/25 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members

    HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across Arizona. PHOENIX, Oct. 28, 2025 /PRNewswire/ -- Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE:HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership i

    10/28/25 11:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care